Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Marcq G, Jarry E, Ouzaid I, Hermieu JF, Henon F, Fantoni JC, Xylinas E.

Ther Adv Urol. 2019 Jan 28;11:1756287218823678. doi: 10.1177/1756287218823678. eCollection 2019 Jan-Dec. Review.

2.

[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer].

Bensalah K, Albiges L, Bernhard JC, Bigot P, Bodin T, Boissier R, Correas JM, Gimel P, Hetet JF, Long JA, Nouhaud FX, Ouzaïd I, Rioux-Leclercq N, Méjean A.

Prog Urol. 2018 Nov;28(12S):S3-S31. doi: 10.1016/j.purol.2018.09.009. Epub 2018 Oct 26. Review. French.

PMID:
30473002
3.

Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia.

Guilhen M, Hennequin C, Ouzaid I, Fumagalli I, Martin V, Guillerm S, Mongiat-Artus P, Ravery V, Desgrandchamps F, Quéro L.

Radiat Oncol. 2018 Oct 24;13(1):209. doi: 10.1186/s13014-018-1149-0.

4.

Do We Truly Care About the Functional Outcomes for Renal Cancer Patients? Multidisciplinarity Is Still Far Away.

Capitanio U, Larcher A, Kriegmair MC, Bertolo R, Salagierski M, Campi R, Klatte T, Trevisani F, Montorsi F, Mir MC, Ouzaid I; Kidney Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology.

Eur Urol. 2019 Feb;75(2):349-350. doi: 10.1016/j.eururo.2018.08.040. Epub 2018 Sep 17. No abstract available.

PMID:
30237026
5.

Suture techniques during laparoscopic and robot-assisted partial nephrectomy: a systematic review and quantitative synthesis of peri-operative outcomes.

Bertolo R, Campi R, Klatte T, Kriegmair MC, Mir MC, Ouzaid I, Salagierski M, Bhayani S, Gill I, Kaouk J, Capitanio U; Young Academic Urologists (YAU) Kidney Cancer working group of the European Urological Association (EAU).

BJU Int. 2018 Sep 14. doi: 10.1111/bju.14537. [Epub ahead of print] Review.

PMID:
30216617
6.

Managing female urethral diverticulum with a standardized technique using a pacifier-trick artifice to facilitate dissection.

Neveü P, Ouzaid I, Xylinas E, Egrot C, Ravery V, Hermieu JF.

Int Urogynecol J. 2018 Sep 3. doi: 10.1007/s00192-018-3754-8. [Epub ahead of print]

PMID:
30178127
7.

Prevention of IVR: a need for investigation.

Ouzaid I, Xylinas E; Young Academic Urologists of the European Association of Urology Urothelial Carcinoma Group.

Jpn J Clin Oncol. 2018 Mar 1;48(3):295-296. doi: 10.1093/jjco/hyx169.

PMID:
29329444
8.

Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.

Xylinas E, Kent M, Dabi Y, Rieken M, Kluth LA, Al Hussein Al Awamlh B, Ouzaid I, Pycha A, Comploj E, Svatek RS, Lotan Y, Karakiewicz PI, Holmang S, Shariat SF.

Urol Oncol. 2018 Mar;36(3):89.e1-89.e5. doi: 10.1016/j.urolonc.2017.11.010. Epub 2017 Dec 6.

PMID:
29221642
9.

Pelvic ureter resection followed by psoas hitch bladder re-implantation.

Eveno C, Ouzaid I, Pocard M.

J Visc Surg. 2017 Oct;154(5):355-359. doi: 10.1016/j.jviscsurg.2017.08.010. Epub 2017 Sep 25. No abstract available.

PMID:
28958824
10.

European temporal trends in the use of lymph node dissection in patients with renal cancer.

Capitanio U, Stewart GD, Larcher A, Ouzaid I, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Salagierski M, Volpe A, Mir MC, Kriegmair M, Terrone C, Brookman-May SD, Montorsi F, Klatte T; Kidney Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU).

Eur J Surg Oncol. 2017 Nov;43(11):2184-2192. doi: 10.1016/j.ejso.2017.07.016. Epub 2017 Aug 3.

PMID:
28801061
11.

Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?

Capitanio U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M, Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May SD.

Eur Urol Focus. 2018 Dec;4(6):972-977. doi: 10.1016/j.euf.2017.02.020. Epub 2017 Mar 21.

PMID:
28753867
12.

Ductal adenocarcinoma of the prostate: Clinical and biological profiles.

Vinceneux A, Bruyère F, Haillot O, Charles T, de la Taille A, Salomon L, Allory Y, Ouzaid I, Choudat L, Rouprêt M, Comperat E, Houede N, Beauval JB, Vourc'h P, Fromont G.

Prostate. 2017 Sep;77(12):1242-1250. doi: 10.1002/pros.23383. Epub 2017 Jul 12.

PMID:
28699202
13.

[Evaluation of the operating results and costs associated with the implementation of a flexible ureteroscopy activity within a university hospital center].

Del Santo K, Audouin M, Ouzaid I, Ravery V, Traxer O.

Prog Urol. 2017 May;27(6):375-380. doi: 10.1016/j.purol.2017.02.004. Epub 2017 Apr 20. French.

PMID:
28434755
14.

[Urethral strictures treated with excision and primary anastomosis: Impact of etiology on care pathways and management].

Jarry L, Ravery V, Daché A, Hermieu JF, Egrot C, Ouzaid I.

Prog Urol. 2017 Mar;27(3):184-189. doi: 10.1016/j.purol.2016.12.013. Epub 2017 Mar 1. French.

PMID:
28258909
15.

Immune checkpoint inhibitors-related orchitis.

Brunet-Possenti F, Opsomer MA, Gomez L, Ouzaid I, Descamps V.

Ann Oncol. 2017 Apr 1;28(4):906-907. doi: 10.1093/annonc/mdw696. No abstract available.

PMID:
28039179
16.

[CCAFU french national guidelines 2016-2018 on renal cancer].

Bensalah K, Albiges L, Bernhard JC, Bigot P, Bodin T, Boissier R, Corréas JM, Gimel P, Long JA, Nouhaud FX, Ouzaïd I, Paparel P, Rioux-Leclercq N, Méjean A.

Prog Urol. 2016 Nov;27 Suppl 1:S27-S51. doi: 10.1016/S1166-7087(16)30702-3. French.

PMID:
27846932
17.

[Introduction of the photoselective vaporization of the prostate in an outpatient setting: Outcomes after the first 100 cases].

Salameh M, Gerbaud F, Daché A, Hermieu JF, Dominique S, Hupertan V, Ravery V, Ouzaid I.

Prog Urol. 2016 Sep - Oct;26(11-12):662-667. doi: 10.1016/j.purol.2016.07.004. Epub 2016 Aug 24. French.

PMID:
27567744
18.

Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.

Roperch JP, Grandchamp B, Desgrandchamps F, Mongiat-Artus P, Ravery V, Ouzaid I, Roupret M, Phe V, Ciofu C, Tubach F, Cussenot O, Incitti R.

BMC Cancer. 2016 Sep 1;16:704. doi: 10.1186/s12885-016-2748-5.

19.

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.

Long JA, Bernhard JC, Bigot P, Lanchon C, Paparel P, Rioux-Leclercq N, Albiges L, Bodin T, Nouhaud FX, Boissier R, Gimel P, Méjean A, Masson-Lecomte A, Grenier N, Cornelis F, Grassano Y, Comat V, Le Clerc QC, Rigaud J, Salomon L, Descotes JL, Sengel C, Roupret M, Verhoest G, Ouzaid I, Arnoux V, Bensalah K; French association of Urology Cancerology Comitee (CCAFU).

World J Urol. 2017 Apr;35(4):649-656. doi: 10.1007/s00345-016-1913-4. Epub 2016 Aug 6.

PMID:
27498139
20.

Mise en place progressive de la photo-vaporisation de prostate en ambulatoire : expérience sur les 100 premiers patients.

Salameh M, Ouzaid I, Daché A, Hupertan V, Dominique S, Hermieu J, Ravery V.

Prog Urol. 2015 Nov;25(13):852-3. doi: 10.1016/j.purol.2015.08.274. French. No abstract available.

PMID:
26544467

Supplemental Content

Loading ...
Support Center